ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Austar Lifesciences Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
- The company is Net-Debt Free
2
Flat results in Jun 26
- RAW MATERIAL COST(Y) Grown by 11.09% (YoY)
- NET PROFIT(Q) Fallen at -60.33%
3
With ROE of 3.61%, it has a Expensive valuation with a 0.39 Price to Book Value
- Over the past year, while the stock has generated a return of -37.17%, its profits have risen by 139.3% ; the PEG ratio of the company is 0.1
4
Below par performance in long term as well as near term
- Along with generating -37.17% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Industrial Manufacturing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Austar Lifesciences Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Austar Lifesciences Ltd.
-35.14%
-0.06
68.53%
Hang Seng Hong Kong
-4.77%
-0.26
18.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.60%
EBIT Growth (5y)
6.41%
EBIT to Interest (avg)
4.02
Debt to EBITDA (avg)
1.57
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
1.60
Tax Ratio
58.63%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.42%
ROE (avg)
9.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.39
EV to EBIT
14.47
EV to EBITDA
5.12
EV to Capital Employed
0.43
EV to Sales
0.25
PEG Ratio
0.08
Dividend Yield
NA
ROCE (Latest)
2.98%
ROE (Latest)
3.61%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 319.63 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 5.04 times
DEBTORS TURNOVER RATIO(HY)
Highest at 1.63 times
-3What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 11.09% (YoY
NET PROFIT(Q)
Fallen at -60.33%
Here's what is working for Austar Lifesciences Ltd.
Operating Cash Flow
Highest at HKD 319.63 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Inventory Turnover Ratio
Highest at 5.04 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 1.63 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Austar Lifesciences Ltd.
Net Profit
Fallen at -60.33%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Raw Material Cost
Grown by 11.09% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
